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To the editors,
Novel coronavirus 19 infection (COVID-19) has
become a global pandemic which originated in Wuhan,
China, in December 2019 and caused worldwide mortality
and morbidity [1]. Turkey had the first coronavirus patient
tested positive on March 10th. Since then the number of
tests and the number of patients with COVID-19 infection
have increased and in less than 2 weeks the numbers
climbed to thousands. In this analysis, we discussed the
characteristics of patients admitted to our hospital for
COVID-19.
We conducted a retrospective study among the patients
who were hospitalized for the novel coronavirus in our
internal medicine clinic between 15th and 28th March,
2020. Demographic characteristics and laboratory values
of patients were recorded. Coronavirus testing was done
with Bio-Speedy COVID-19 RT-qPCR kit. All the patients
were also screened with chest X-ray and CT.
We evaluated 70 patients, 49 of whom were men
(70.0%). Mean age was 55.8 (min 24, max 87). Thirtyseven patients (52.9%) tested positive for coronavirus
infection with PCR. Patients who have negative PCR test
results were also considered infected according to the
radiological and clinical findings after other diagnoses are
excluded with the viral respiratory panel. Seven patients
(10.0%) had a recent travel history to disease-endemic
countries, 29 (41.4%) had contact with suspected cases,
and 10 (14.2%) were medical workers. Cough and fever
were present in every patient except one (mean duration
3.7 and 3.5 days, respectively) and shortness of breath
was present in 26 patients (37.1%) whereas myalgia was
present in every patient (mean duration 0.7 days and 5.1
days, respectively). Twenty (28.6%) patients were smokers,
23 patients (32.9%) had hypertension (HT).
Among patients with HT, 6 (26.1%) were treated
with angiotensin-converting enzyme (ACE) inhibitors,
8 (34.8%) with angiotensin receptor blockers (ARBs), 9
(39.1%) with calcium channel blockers, 5 (21.7%) with
beta-blockers, 5 (21.7%) with thiazide diuretics and 2
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(8.7%) with alpha-blockers. We continued hypertension
medications during the hospital stay of the patients.
There were 12 patients (17.1%) with diabetes, 6 patients
(8.6%) with coronary heart disease, 2 patients (6.7%)
with hematologic malignancy, and 3 patients (4.2%) with
solid malignancy. Four patients had chronic obstructive
pulmonary disease. Two patients (2%) were sent home
because no hospital care was required. Eleven patients
(15.7%), whose condition deteriorated, were transferred
to the ICU. The remainders were followed in the clinic.
There were statistically significant differences in SpO2,
pulse rate, respiratory rate, hemoglobin, lymphocytes,
monocytes,
aspartate
aminotransferase,
lactate
dehydrogenase, c-reactive protein, sodium, potassium,
total protein, albumin, d-dimer, fibrinogen, activated
partial thromboplastin time, troponin, and procalcitonin
between these patients and patients followed in clinics (P <
0.05) (Table). There was no difference between parameters
of patients with positive PCR and negative PCR results
among the cohort.
Chest CT scans showed infiltrations and ground-glass
opacity. Patients admitted to ICU had more consolidated
areas and infiltrations (Figure 1) than patients followed
in clinics (Figure 2). All patients were started on
hydroxychloroquine 2 × 200 mg, azithromycin 500 mg
on day 1 followed by 250 mg for 4 days, ceftriaxone 1 × 2
g, and oseltamivir 2 × 75 mg. Other antiviral agents were
added if patients’ condition deteriorated. Oxygen therapy
was also administered to patients whose SpO2 was under
94%.
To the best of our knowledge, this is the first report
of COVID-19 infection in Turkey. Numerous cohorts
unite in one risk factor: age [2–4]. Li et al. reported the
first 425 patients from Wuhan, China [5] and median age
of their patients was 59. Our patients’ mean age was 55.8.
Additionally, the mean age of patients treated in the ICU
was 70, and it was statistically higher than that of patients
treated in clinics. Zhou et al. [2] reported that age, d-dimer
levels greater than 1 μg/mL, high-sensitivity cardiac
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Table. Comparison of patients in clinics and in intensive care unit.
Patients followed in clinics
(n = 57)

Patients followed in ICU
(n = 11)

P-value

Age (years)

53.9 ± 14.4

70.1 ± 9.3

<0.001*

Sex

39 male (68.4%)

8 male (72.7%)

SpO2 (%)

95.1 ± 2.7

88.3 ± 4.8

<0.001*

Pulse (per min)

95.7 ± 8.3

105.1 ± 7.7

0.002*

Respiratory Rate (per min)

19.0 ± 3.1

30.2 ± 3.2

<0.001*

pH

7.3 ± 0.0

7.4 ± 0.1

0.009*

pCO2 (mmHg)

42.8 ± 8.1

37.1 ± 10.9

0.022*

HCO3 (mmol/L)

24.8 ± 2.3

23.7 ± 3.2

0.299

Lactate (mEq/L)

1.5 ± 0,4

1.6 ± 0.8

0.556

Hemoglobin (g/dL)

13.4 ± 1.5

11.7 ± 1.9

0.015*

Platelets (per microliter)

186684.2 ± 56788.5

189545.4 ± 54869.5

0.877

WBC (per microliter)

5674.7 ± 1666.6

5578.1 ± 2580.0

0.907

Neutrophils (%)

4048.5 ± 1515.1

4662.7 ± 2623.4

0.901

Lymphocytes (%)

1047.1 ± 399.0

562.7 ± 284.7

<0.001*

Monocytes (%)

466.4 ± 181.5

308.1 ± 153.0

0.008*

BUN (mg/dL)

13.9 ± 6.1

21.3 ± 16.9

0.277

Creatinine (mg/dL)

0.9 ± 0.3

1.1 ± 0.7

0.609

Sodium (mEq/L)

137.2 ± 3.0

134.8 ± 4.4

0.08

Cl (mEq/L)

97.9 ± 3.0

95.9 ± 4.9

0.183

K (mEq/L)

4.3 ± 0.4

4.0 ± 0.4

0.044*

Glucose (mg/dL)

122.9 ± 30.1

128.4 ± 14.4

0.094

AST (U/L)

36.3 ± 21.1

64.8 ± 41.9

0.016*

ALT (U/L)

32.0 ± 25.9

37.5 ± 25.9

0.426

GGT (U/L)

33.3 ± 29.5

56.9 ± 47.7

0.102

ALP (U/L)

63.7 ± 20.2

81.0 ± 47.7

0.707

LDH (U/L)

299.4 ± 105.6

474.8 ± 244.1

0.008*

Total protein (g/dL)

7.1 ± 0.5

6.6 ± 0.4

0.003*

Albumin (g/dL)

3.9 ± 0.4

3.3 ± 0.3

<0.001*

CRP (mg/L)

50 ± 36.5

129.5 ± 69.2

<0.001*

Procalcitonin (ng/mL)

0.13 ± 0.2

0.3 ± 0.2

0.001*

Ferritin (ng/mL)

692.1 ± 891.8

818.3 ± 470.4

0.143

D-dimer (μg/mL)

816.6 ± 609.7

1950.0 ± 2033.9

0.002*

Troponin (pg/mL)

6.4 ± 6.5

27.0 ± 26.1

<0.001*

Pro-BNP (pg/mL)

133.7 ± 457.6

522.7 ± 584.9

<0.001*

Fibrinogen (mg/dL)

493.9 ± 89.1

582.9 ± 116.0

0.045*

APTT (seconds)

28.4 ± 2.7

34.9 ± 6.0

0.001*

WBC stands for white blood count, BUN for blood urea nitrogen, Cl for chloride, K for potassium, ALT for
alanine transaminase, AST for aspartate transaminase, GGT for gamma-glutamyl transferase, ALP for alkaline
phosphatase, LDH for lactate dehydrogenase, CRP for c-reactive protein, pro-BNP for pro-brain natriuretic
peptide, APTT for activated partial thromboplastin time, and ICU for intensive care unit.
Statistical analysis was conducted with SPSS v16. Data were tested for normality and parametric data was
compared with Student’s t-test whereas nonparametric data was compared with the Mann–Whitney U test. Data
were given with mean and standard deviation. A P-value less than 0.05 was identified as statistically significant.
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Figure 1. Computer tomography imaging of patients in intensive care unit.

Figure 2. Computer tomography imaging of patients in clinics.
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troponin I, lactate dehydrogenase and lymphopenia were
associated with severe disease. Our study results were
compatible with those of this report.
Patients are mostly screened with RT-qPCR tests;
however, there are publications of false-negative reports
[6]. CT imaging of lungs also plays a crucial role in
diagnosis [7]. Some reports say radiologic imaging has
provided more insight for the detection of the disease
and CT imaging is more reliable than PCR testing [7,8].
Nevertheless, clinical presentation and demographic
features of the patients give clues about progression of the
disease [9]. In our study, some patients whose radiology
were compatible with COVID-19 but had negative PCR
test results were assumed to be infected.

In conclusion along with the strict preventive measures
at the population level and the help of dedicated healthcare
workers, we hope to defeat the novel coronavirus infection
which is a completely unusual and severe threat to public
health.
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